David Huss

David Huss

Company: Shape Therapeutics

Job title: Chief Scientific Officer

Seminars:

High Efficiency RNA Editing Gene Therapy for the Treatment of Neurological Disorders 4:40 pm

Redirecting the fully human, endogenous ADAR enzyme enables site-specific RNA editing to correct point mutations, control RNA splicing or modulate protein expression and function. Importantly, this is done without risk of DNA damage or foreign protein immunogenicity The RNAfixTM technology platform combines high throughput screening with generative machine learning models to produce highly efficient and…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.